(125 days)
The TaiDoc Pro I Glucose Test Strip is intended for use in the quantitative measurement of glucose in fresh capillary whole blood from the finger and the following alternative sites: the palm, the forearm, the upper-arm, the calf and the thigh. The test strips are for use with Clever Chek TD-4222, Clever Chek TD-4230, Clever Chek TD-4231 Blood Glucose Meters and Clever Chek TD-3250C, and Fora Comfort 2 in 1 TD-3260 Blood Glucose plus Blood Pressure Monitors Only. It is intended for use by healthcare professionals and people with diabetes mellitus at home as an aid in monitoring the effectiveness of diabetes control program. It is not intended for the diagnosis of or screening for diabetes mellitus, and is not intended for use on neonates. Professionals may use the test strips to test capillary and venous blood samples, but lay user may not test venous blood samples.
The TaiDoc Pro I Glucose Test Strip is designed to quantitatively measure the concentration of glucose in whole blood. The test principle of the system utilize an electrochemical method-based meter and dry reagent biosensor (test strips) for blood glucose testing. The size of the current is proportional to the amount of qlucose present in the sample, providing a quantitative measurement of glucose in fresh whole blood and control solutions.
The provided text describes a 510(k) summary for the TaiDoc Pro I Glucose Test Strip, but it does not contain the detailed performance study results, acceptance criteria, or most of the specific information requested in the prompt.
The document states:
- "The performance of TaiDoc Pro | Glucose Test Strip was studied in the laboratory and in clinical settings by healthcare professionals and lay users. The studies demonstrated that the performance of this system meets its intended use."
- "TaiDoc Pro I Glucose Test Strip demonstrates satisfactory performance and is suitable for its intended use."
However, it does not provide a table of acceptance criteria, reported device performance metrics (like accuracy, precision, bias), sample sizes for test sets, data provenance, number of experts for ground truth, adjudication methods, details on MRMC studies, standalone performance, type of ground truth used, or information about the training set.
Therefore, I cannot fulfill your request for a table of acceptance criteria and a detailed description of the study with the specific information you asked for based solely on the provided text.
To answer your request, I would need access to the actual performance study report, which is typically a much more detailed document than the 510(k) summary.
§ 862.1345 Glucose test system.
(a)
Identification. A glucose test system is a device intended to measure glucose quantitatively in blood and other body fluids. Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia, and idiopathic hypoglycemia, and of pancreatic islet cell carcinoma.(b)
Classification. Class II (special controls). The device, when it is solely intended for use as a drink to test glucose tolerance, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.